TRexBio

TRexBio is a biotechnology company in the exploratory stage, leveraging cutting-edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapies for cancer and inflammatory diseases. Our robust "Deep Biology" discovery engine maps Treg behavior in human tissues to disease processes, enabling us to identify and characterize new targets for therapeutic intervention. Using this platform, TRexBio is building a broad portfolio of novel therapies to modulate the immune system and restore immune homeostasis in human tissues.